Ackman, Valeant Target Of Lawsuit; Will Allergan’s Pyott Join Plaintiffs?Mark Melin
A new class action lawsuit is doing what some had anticipated government regulators would do: charging that Bill Ackman, his hedge fund, Pershing Square Capital Management, and Valeant Pharmaceuticals Intl Inc, engaged in insider trading.
The suit, brought by investors who sold stock between February and April, a period when Ackman's Pershing Square Capital Management had knowledge of a pending acquisition of Allergan Inc. and discreetly purchased nearly 10% of Allergan's stock . . .
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up below and support quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email email@example.com and we will get back to you as quick as humanly possible - we love (all our but in particular our) paying readers